You are here : Home Healthcare Payment Link for Sterlitech Corporation - Track etched Membrane Market & Pharmaceutical Filtration Market Drug formulations ATC Antiinfectives for Systemic Use Vaccines Animal Vaccines

Global DNA vaccines Market Research Report

DNA vaccines and Live attenuated vaccines, Inactivated vaccines, Toxoid vaccines, Recombinant vaccines, Conjugate vaccines, Sub-unit vaccines and Other Vaccine technology adds up to total Animal Vaccines market.

DNA vaccines can be segmented by Types, Geographies, MacroIndicators and Companies. Types of this market are Preventive and Therapeutic. Geographies of this market are North America, Europe, Asia, Rest of World and Other Geographies. MacroIndicators of this market are Healthcare Expenditure. Companies of this market are Pfizer Inc, Sanofi, Merck & Co., Inc., Virbac, Bayer Pharmaceuticals and Other Companies.

Key Questions Answered

What are market estimates and forecasts; which of DNA vaccines markets are doing well and which are not?
What is the competitive landscape; How companies like Pfizer Inc, Sanofi and Merck & Co., Inc. doing in DNA vaccines?

What makes our report unique?

This report provides market sizing and forecast for the DNA vaccines market. It also provides market sizing and forecast along with the drivers/inhibitors/opportunity analysis for each of the micro markets.
The report provides deep dive competitive landscape covering the top players such as Pfizer Inc, Sanofi, Merck & Co., Inc. and Virbac.
The reports provides benchmarking insight on the top players Pfizer Inc, Sanofi, Merck & Co., Inc. and Virbac.
The report provide competitive intelligence on Pfizer Inc, Sanofi, Merck & Co., Inc. and Virbac.

Audience for this report

Global DNA vaccines companies
Manufacturing Companies
Traders, distributors, and suppliers
Governmental and research organizations
Associations and industry bodies
Technology providers

	PRODUCT TITLE	PUBLISHED
	North American DNA vaccines Market The North American DNA animal vaccine market, mainly driven by the growing prevalence of animal diseases and increasing incidences of zoonotic diseases in humans, was valued at $45.6 million in 2013 and is expected to reach $63.9 million by 2018, at a CAGR of 7.0% during the forecast period. The report on this market analyzes it under six segments/products: aquaculture, companion animal vaccines, equine, livestock, porcine, and poultry. The prominent players in the market are Sanofi-Aventis, Merck, Pfizer, Inc., Bayer AG, and Virbac.	Upcoming
	European DNA vaccines Market The European DNA animal vaccine market, mainly driven by the growing prevalence of animal diseases and increasing incidences of zoonotic diseases in humans, was valued at $54.2 million in 2013 and is expected to reach $80.2 million by 2018, at a CAGR of 8.2% during the forecast period. The report analyzes the market by six segments/products: aquaculture, companion animal vaccines, equine, livestock, porcine, and poultry. The prominent players in the market are Sanofi-Aventis, Merck, Pfizer, Inc., Bayer AG, and Virbac.	Upcoming
	Asian DNA vaccines Market The Asian DNA animal vaccine market, mainly driven by the growing prevalence of animal diseases and increasing incidences of zoonotic diseases in humans, was valued at $24.2 million in 2013 and is expected to reach $47.6 million by 2018, at a CAGR of 14.5%. The report analyzes the market by six segments/products: aquaculture, companion animal vaccines, equine, livestock, porcine, and poultry. The prominent players in the market are Sanofi-Aventis, Merck, Pfizer, Inc., Bayer AG, and Virbac.	Upcoming

3 of 3 items

3 reports | Show

Connect With Us

US/CAN : +1-888-502-0539

sales@micromarketmonitor.com

Subscription

Animal Vaccines